Back to top

Amedisys (AMED) Gets a Hold from Oppenheimer

In a report released today, from Oppenheimer maintained a Hold rating on Amedisys. The company’s shares opened today at $99.23. In addition to Oppe...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amedisys, Inc. (AMED)